RADOPEP-GM
Composition: Glibenclamide IP 5mg, Pioglitazone Hydrochloride IP 15mg, and Metformin Hydrochloride 500mg
RADOPEP-GM
is a comprehensive oral therapy tailored for individuals requiring effective management of type 2 diabetes. This dynamic trio, consisting of Glibenclamide, Pioglitazone, and Metformin Hydrochloride, works synergistically to improve the body's insulin utilization and helps maintain healthy blood sugar levels.
The combination of Glibenclamide IP 5mg, Pioglitazone Hydrochloride 15mg, and Metformin Hydrochloride 500mg is a fixed-dose combination medication used to treat type 2 diabetes. It combines three different classes of diabetes medications:
Glibenclamide IP 5mg: A sulfonylurea that helps to stimulate the pancreas to produce more insulin.
Pioglitazone Hydrochloride 15mg: A thiazolidinedione that helps to improve insulin sensitivity.
Metformin Hydrochloride 500mg: A biguanide that helps to improve insulin sensitivity and reduce blood sugar levels.
Common uses of this combination include:
Type 2 diabetes: To help control blood sugar levels in people with type 2 diabetes.
Weight loss: Metformin can help with weight loss, which can improve blood sugar control.
Strip: 10x10 tablets